Cover storyContinued Process Verification In Pharma: What Literature Shows
CPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.
Cover storyCPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.

FDA grants accelerated approval to AstraZeneca's camizestrant with a CDK4/6 inhibitor for ESR1-mutated HR+/HER2- metastatic breast cancer, tied to Guardant360 CDx companion diagnostic.

FDA confirms hidden sildenafil in ZUBB weight-loss supplement intercepted via international mail, raising incoming-material control concerns for QA teams.

Tarsus Pharmaceuticals closes Alkeus acquisition, adding FDA Breakthrough-designated ALK-001 for Stargardt disease to its Phase 3 pipeline.

S&P upgrades Teva to BBB-, completing investment-grade ratings from all three major agencies and signalling durable generics stabilisation.
Latest edition

Sep 28
Oct 06From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
